Stock screener

ZLAB

Conviction 73HealthcareScan · Mon, Aug 10, 2026
ZLAB$23.59+1.16%
ResistanceSupportVol 14Insider sell
63 bars
3
2
2
Vol MA14 728.56K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Zai Lab LtdPHARMACEUTICAL PREPARATIONSwww.zailaboratory.com ↗
Price23.59
Change+1.16%
Gap-3.11%
Rel volume2.02×
Avg volume723.58K
Avg $ vol14.88M
SMA 2019.80
SMA 5018.83
SMA 20019.68
Price vs 50+25.28%
Price vs 200+19.86%
MA stackmixed
50/200 cross—
Supertrendup · 19.62
RSI (14)76
MACD hist0.44
MACD crossbull · 1d
Stoch %K / %D92 / 85
ADX (14)22
+DI / −DI44 / 14
RSI divergence—
MACD divergence—
ATR %+4.48%
ADR %4.36%
52w high35.73
52w low16.30
From 52w high-33.98%
Above 52w low+44.72%
New 52w highNo
SqueezeOff
Bollinger width31.19%
%B1.11
Donchian pos92.27%
Donchian high24.07
Donchian low17.92
AVWAP (52w high)21.69
vs AVWAP high+8.76%
AVWAP (52w low)19.39
vs AVWAP low+21.66%
OBV trendFlat
Chaikin MF (20)0.14
Today vs 20d2.02×
Avg vol (14d)728.56K
Avg vol (20d)723.58K
Avg $ vol (20d)14.88M
Market cap—
RS 3m (vs SPY)+12.29%
RS 6m (vs SPY)+23.22%
RS line new highYes
Trend template4/8
Technical rank89.2
1 week+29.76%
1 month+15.13%
3 months+26.83%
6 months+31.06%
1 year-30.78%
YTD+36.12%
P/E-11.77
P/B3.40
P/S4.52
P/FCF-13.00
EPS-0.1600
Div yield—
ROE-28.92%
ROA-16.33%
Debt/Eq0.39
Current2.13
EV/EBITDA-7.91
Gross margin—
Net margin-38.40%
Rev growth14.98%
EPS growth31.72%
Price target32.65
Target upside40.04%
Analyst ratingBuy
Institutional24.92%
Ent. value1.7B
Revenue105.75M
Net income-50.83M
Gross profit—
Free cash flow-158.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out113.41M
Employees1.8K
ListedWed, Sep 20, 2017
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction73 / 100
Pattern quality—
Tech rank89.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance20.90
Support17.21
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ZLAB

All disclosures →
No recent disclosed trades by Congress in ZLAB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ZLAB · 4 buys · 6 sells

InsiderSideShares
Chen Yajing
Chief Financial Officer · American Depositary Shares · 2026-06-26
Sell2.26K
Edmondson Frazor Titus III
Chief Legal Officer · American Depositary Shares · 2026-06-26
Sell4.1K
Du Ying
Chairperson & CEO · American Depositary Shares · 2026-06-26
Sell24.54K
Chen Yajing
Chief Financial Officer · Restricted Share Units · 2026-06-25
Exercise6.25K
Edmondson Frazor Titus III
Chief Legal Officer · American Depositary Shares · 2026-06-25
Exercise14.6K
Du Ying
Chairperson & CEO · Restricted Share Units · 2026-06-25
Exercise58.8K
Edmondson Frazor Titus III
Chief Legal Officer · Restricted Share Units · 2026-06-25
Exercise14.6K
Du Ying
Chairperson & CEO · American Depositary Shares · 2026-06-25
Exercise58.8K
Chen Yajing
Chief Financial Officer · American Depositary Shares · 2026-06-25
Exercise6.25K
DIEKMAN JOHN D
Director · American Depositary Shares · 2026-06-17
Grant22.37K

SEC filings

EDGAR filings in ZLAB · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.